Having an influencer endorse your product seems like a great idea, but when messages go south, both companies and endorsers may be on the hook.
Antitrust law isn’t—or shouldn’t be—about breaking up businesses just for being big.
It may sound like a good alternative to mandating, but it likely won't have the intended effect of increasing vaccination rates—and could create administrative and legal headaches down the road.
It's a question as old as America itself: When state and federal laws conflict, which one controls? For companies, that question is becoming essential.
To effectively protect competition in the digital age, you need to focus on the true source of power: not scale, but business model. Here's how.
There’s a dangerous tendency to assume this executive has a firm handle on all aspects of compliance risk. In reality, even the best will admit in private that they, too, have blind spots. Here are three.
Once-sidelined enforcement priorities will likely take a front seat once again. Here's what CEOs need to know.
The newest Covid relief bill will provide much-needed funds for companies still struggling. But it will also open them to new liability.
Delaware Court invalidates Williams’ Poison Pill and finds that Williams’ board has breached its fiduciary duties. What directors and CEOs need to know.
Companies should take steps now to minimize risk in a rapidly evolving legal landscape governing the use of biometric technology, which is sure to see many significant changes over the course of 2021.